RE-VANA
Developing photocrosslinked technologies for delivery of a wide range of therapeutics that may dramatically extend the time between intravitreal.
Launch date
Employees
Market cap
-
Enterprise valuation
$48—71m (Dealroom.co estimates Dec 2022.)
Company register number NI638333
Belfast Northern Ireland (HQ)
Authorizing premium user...